We have investigated the relationship between disease progression and several immunologic and virologic markers of HIV infection. Plasma samples from infants born to HIV-1infected mothers were collected at birth and at 1, 2, 4, 6, 9, 12, 15, and 18 mo of age and subsequently were assayed every 6 mo for viral load, viral phenotype, and lymphocyte populations. A cutoff level of 25% indicative of a preserved immunologic status, both of CD4 and CD8 blood T cells, was associated with significant differences in disease progression (p= 0.04 and 0.02, respectively). Infants with median CD4 T cells “25% had a relative risk of progression to AIDS 3.35-fold higher than those with CD4 above this level (p= 0.05). The relative risk of progression to AIDS for infants with median CD8 “25% was 4.95-fold higher than for those with CD8 percent above this threshold (p= 0.03). Similarly, a cutoff level of viral load of 5.5 log10copies/mL was indicative of a worse prognosis. Infants with median viral load >5.5 log10copies/mL had a relative risk of progression to AIDS 23.72-fold higher (p= 0.0001) than those with median viral load below this threshold. Interestingly, changes from a slow replication and low titer to a rapid replication and high titer of virus and from nonsyncytium-inducing to syncytium-inducing viral phenotype were indicative of progression to AIDS. Our results indicate that biologic phenotype of viral isolates and CD8 T-lymphocyte percentages in peripheral blood as well as viral load and CD4 T-lymphocyte percentages could predict rapid progression to advanced HIV-1 disease in HIV-1infected infants.© International Pediatrics Research Foundation, Inc. 2000. All Rights Reserved.
CITATION STYLE
Resino, S., Gurbindo, D., Cano, J. M. B., Sanchez-Ram, S., & Muoz-Fernndez, A. A. (2000). Predictive markers of clinical outcome in vertically HIV-1Infected infants. A prospective longitudinal study. Pediatric Research, 47(4), 509–515. https://doi.org/10.1203/00006450-200004000-00016
Mendeley helps you to discover research relevant for your work.